glp-1 agonist consultation process Agonists - What is it? GLP1 agonists: current and future
Description
Effects of onceweekly exenatide on cardiovascular outcomes in type 2 diabetes
Nrregaard PK, Deryabina MA, Tofteng Shelton P, Fog JU, Daugaard JR, Eriksson PO, et al
In addition, a large number of clinical studies have shown that GLP-/GIP dual agonists can reduce LFC, VAT, and body weight, and have an improvement effect on both NAFLD and NASH [131,132]
This multi-system impact explains why GLP-1 medications produce benefits beyond just weight loss
2022;377:e068172
How should GLP-1 receptor agonists be managed in the perioperative period
